Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics
Go back to Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics| (NASDAQ: AKTX) | Delayed: 10.97 -0.53 (4.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.50 | 52 Week High | $19.75 | |||
| Open | $11.50 | 52 Week Low | $7.63 | |||
| Day High | $11.58 | P/E | N/A | |||
| Day Low | $10.70 | EPS | $0.00 | |||
| Volume | 11,506 | |||||
| (NASDAQ: AKTX) | Delayed: 10.97 -0.53 (4.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.50 | 52 Week High | $19.75 | |||
| Open | $11.50 | 52 Week Low | $7.63 | |||
| Day High | $11.58 | P/E | N/A | |||
| Day Low | $10.70 | EPS | $0.00 | |||
| Volume | 11,506 | |||||

